article · Journal of Dermatology Research and Therapy
Mycosis fungoides and its variants account for almost 50% of all cutaneous lymphomas and around 65% of cutaneous T-cell lymphomas. We report the clinical case of a patient with a tumoral nodule, with progressive evolution and rapid transformation. Our patient was undergoing chemotherapy. After mycosis fungoides, CD30+ cutaneous lymphoproliferations are the most frequent pathologies among cutaneous T-cell lymphomas, accounting for 20% of this group.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.23937/2469-5750/1510125
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
